Ultrasound-Guided Baxter Nerve, Flexor Digitorum Brevis, or Combined Injections for Plantar Heel Pain Associated With Calcaneal Spur: A Prospective Randomized Controlled Trial

Background Plantar heel pain associated with calcaneal spur is common. This randomized controlled trial compared ultrasound-guided Baxter nerve, flexor digitorum brevis (FDB) origin, and combined injections. Methods A total of 210 patients with plantar heel pain associated with calcaneal spur were randomized 1:1:1 using a computer-generated block randomization sequence. Participants received ultrasound-guided injection targeting the Baxter nerve, FDB origin, or both sites. The primary outcome was longitudinal change in pain intensity measured using a 0- to 10-cm Visual Analog Scale (VAS) at 1, 3, and 6 months. The secondary outcome was longitudinal change in the Foot Function Index (FFI). Outcomes were analyzed using linear mixed-effects models with treatment, time, treatment-by-time interaction, and baseline outcome values as fixed effects and participant as a random intercept. Results Of 210 participants, 202 completed follow-up and were included in the analysis. Treatment-by-time interaction was significant for VAS (χ² = 155.21, df = 4, P < .001) and FFI (χ² = 148.65, df = 4, P < .001). At 6 months, the adjusted VAS difference was − 4.77 points (95% CI, − 5.67 to − 3.88; Holm-adjusted P < .001) for Baxter nerve versus FDB injection and − 4.52 points (95% CI, − 5.41 to − 3.63; Holm-adjusted P < .001) versus combined injection. FFI differences were − 0.343 (95% CI, − 0.412 to − 0.273; Holm-adjusted P < .001) and − 0.360 (95% CI, − 0.430 to − 0.290; Holm-adjusted P < .001), respectively. No treatment-related adverse events were observed. Conclusions In patients with plantar heel pain associated with calcaneal spur, ultrasound-guided Baxter nerve injection resulted in greater improvements in pain and foot function through 6 months than FDB origin or combined injection. These findings support Baxter nerve-targeted injection as an effective treatment option. Trial registration ClinicalTrials.gov, NCT07884695. First posted 20 October 2026. Retrospectively registered.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-18
DOI
https://doi.org/10.21203/rs.3.rs-11485559/v1
Primary Topic
Foot and Ankle Surgery
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Ultrasound-Guided Baxter Nerve, Flexor Digitorum Brevis, or Combined Injections for Plantar Heel Pain Associated With Calcaneal Spur: A Prospective Randomized Controlled Trial

Süleyman Kaan Öner, Sabit Numan Kuyubaşı, Turan Cihan Dülgeroğlu, Emre Çilingir et al.
1 links
Research Square
Foot and Ankle Surgery
preprint

Ultrasound-Guided Baxter Nerve, Flexor Digitorum Brevis, or Combined Injections for Plantar Heel Pain Associated With Calcaneal Spur: A Prospective Randomized Controlled Trial

Süleyman Kaan Öner, Sabit Numan Kuyubaşı, Turan Cihan Dülgeroğlu, Emre Çilingir, Nihat Demirhan Demirkıran, Cengiz ARSLAN
preprint en

Abstract

Background Plantar heel pain associated with calcaneal spur is common. This randomized controlled trial compared ultrasound-guided Baxter nerve, flexor digitorum brevis (FDB) origin, and combined injections. Methods A total of 210 patients with plantar heel pain associated with calcaneal spur were randomized 1:1:1 using a computer-generated block randomization sequence. Participants received ultrasound-guided injection targeting the Baxter nerve, FDB origin, or both sites. The primary outcome was longitudinal change in pain intensity measured using a 0- to 10-cm Visual Analog Scale (VAS) at 1, 3, and 6 months. The secondary outcome was longitudinal change in the Foot Function Index (FFI). Outcomes were analyzed using linear mixed-effects models with treatment, time, treatment-by-time interaction, and baseline outcome values as fixed effects and participant as a random intercept. Results Of 210 participants, 202 completed follow-up and were included in the analysis. Treatment-by-time interaction was significant for VAS (χ² = 155.21, df = 4, P < .001) and FFI (χ² = 148.65, df = 4, P < .001). At 6 months, the adjusted VAS difference was − 4.77 points (95% CI, − 5.67 to − 3.88; Holm-adjusted P < .001) for Baxter nerve versus FDB injection and − 4.52 points (95% CI, − 5.41 to − 3.63; Holm-adjusted P < .001) versus combined injection. FFI differences were − 0.343 (95% CI, − 0.412 to − 0.273; Holm-adjusted P < .001) and − 0.360 (95% CI, − 0.430 to − 0.290; Holm-adjusted P < .001), respectively. No treatment-related adverse events were observed. Conclusions In patients with plantar heel pain associated with calcaneal spur, ultrasound-guided Baxter nerve injection resulted in greater improvements in pain and foot function through 6 months than FDB origin or combined injection. These findings support Baxter nerve-targeted injection as an effective treatment option. Trial registration ClinicalTrials.gov, NCT07884695. First posted 20 October 2026. Retrospectively registered.

Research Square
Ministry of Health (TR), Kutahya Saglik Bilimleri Universitesi (TR)
Good health and well-being
Foot and Ankle Surgery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon